Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study): study protocol for a randomised controlled trial

Catherine Brennand, Alexander von Wilamowitz-Moellendorff, Sarah Dunn, Jennifer Wilkinson, Thomas Chadwick, Laura Ternent, Yemi Oluboyede, Ruth Wood, Katherine Walton, Mandy Fader, James N’Dow, Mohamed Abdel-Fattah, Doreen McClurg, Paul Little, Paul Hilton, Anthony Timoney, Nicola Morris, Nikesh Thiruchelvam, James Larcombe, Simon HarrisonHeather Armstrong, Elaine McColl, Robert Pickard

Research output: Contribution to journalArticle

100 Downloads (Pure)

Abstract

Clean intermittent self-catheterisation is an important management option for people who cannot empty their bladder effectively. Recurrent urinary tract infections are common in these patients. Data from recent studies suggest that antibiotic prophylaxis may be beneficial in reducing infection risk, but the effectiveness of this intervention remains uncertain. This is a 52-site, patient randomised superiority trial set in routine care comparing an experimental strategy of once daily antibiotic prophylaxis for 12 months against a control strategy of no prophylaxis in people who carry out self-catheterisation and suffer recurrent urinary tract infections. The primary outcome is number of urinary tract infections during a 12-month treatment period. Both groups will otherwise receive usual care including on demand treatment courses of antibiotics for urinary tract infection. Participants and their clinicians will not be blinded to the allocated intervention, but central trial staff managing and analysing trial data will, as far as possible, be unaware of participant allocation. The analysis will follow intention-to-treat principles.
Original languageEnglish
JournalTrials
Volume17
Issue number276
Early online date4 Jun 2016
DOIs
Publication statusPublished - Jun 2016

Keywords

  • antibiotic treatment
  • bladder catheterisation
  • infection risk

Fingerprint Dive into the research topics of 'Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study): study protocol for a randomised controlled trial'. Together they form a unique fingerprint.

  • Cite this

    Brennand, C., von Wilamowitz-Moellendorff, A., Dunn, S., Wilkinson, J., Chadwick, T., Ternent, L., Oluboyede, Y., Wood, R., Walton, K., Fader, M., N’Dow, J., Abdel-Fattah, M., McClurg, D., Little, P., Hilton, P., Timoney, A., Morris, N., Thiruchelvam, N., Larcombe, J., ... Pickard, R. (2016). Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study): study protocol for a randomised controlled trial. Trials, 17(276). https://doi.org/10.1186/s13063-016-1389-y